Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018

JAMA. 2020 Jul 28;324(4):395-397. doi: 10.1001/jama.2020.7312.

Abstract

This study uses national pharmacy claims data to describes trends in prescriptions for HIV preexposure prophylaxis (PrEP) overall and by specialty between 2012 and 2018.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Drug Utilization / trends
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Practice Patterns, Physicians' / trends*
  • Pre-Exposure Prophylaxis / trends*
  • United States
  • Young Adult

Substances

  • Anti-HIV Agents